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Abstract
  .In a search for Alzheimer b-amyloid peptide precursor ligands, Potempska et al. Arch. Biochem. Biophys. 1993 304,
.448 found that histones bind with high affinity and specificity to the secreted precursor. Because exogenous histones can be
cytotoxic, we compared the effects of histones on the viability of cells which produce little b-amyloid peptide precursor
 .  .U-937 to those on cells that produce twenty times as much precursor COS-7 . Addition of purified histones caused
 .necrosis of U-937 cells histone H4, LD s1.5 mM . Extracellular A b precursor in the submicromolar range prevented50
histone-induced U-937 cell necrosis. Cell-surface precursor also reduced histone toxicity: COS-7 cells were less sensitive to
 .the toxic effects of histone H4 LD s5.4 mM . COS-7 cells in which the expression of an APP mRNA-directed ribozyme50
 .reduced the synthesis of the protein by up to 80% were more sensitive to histone H4 LD s3.2 mM than cells that50
expressed the vector alone. Histone H4 binds to cell-associated A b precursor. Cells expressing the A b precursor-directed
ribozyme bound less 125I-labeled histone H4 than those expressing the vector alone. In the limited extracellular space of
tissues in vivo, both secreted and cell-surface A b precursor protein may play significant roles in trapping chromatin or
histones and removing them from the extracellular milieu.
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1. Introduction
 .The b-amyloid peptide precursors APPs com-
prise a group of at least 9 alternatively-spliced pro-
teins, secreted as well as integral to cell membranes,
whose function or functions are not fully understood.
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Since the expression of some forms of APP is cell- or
tissue-specific or depends on the state of differentia-
tion or activation of the cell, the functions of APP are
likely to be diverse. Several roles for APP in cell
 .metabolism have been described: including a a pro-
tease inhibitor, both as a generally secreted fragment
w xfrom many cell types, protease nexin 2 1,2 , and as
w xstored in platelet alpha secretory granules 3 and
w x  .neutrophil phagocytic granules 4 , b a growth fac-
w x  . w x  .tor 5 , c an adhesion protein 6 , d metal ion
w x  . w xreceptor 7,8 and e extracellular matrix receptor 9 .
In addition, APP has been located in every membrane
compartment of the cell with the exception of the
w xmitochondrial membranes 10,11 .
To elucidate the functions of APP, we searched for
proteins that bound to the secreted fragment of APP
 . w xsAPP 12,13 . These studies showed that, among
the binding proteins identified in brain extracts, the
histones bound with the highest affinity. Among the
histone subtypes, H4 bound with the greatest avidity.
w xSince exogenous histones can be cytotoxic 14,15 ,
we investigated the physiological relevance of the
sAPP-histone interaction by examining the effects of
 .histones on cells U-937 adapted to grow in serum-
free medium. We examined the capacity of sAPP to
protect U-937 cells from histone toxicity. We com-
pared the effects of purified histone H4 on cells that
 .produce abundant APP COS-7 cells with those on
cells which synthesize little APP APP-ribozyme-ex-
.pressing COS-7 cells , and we measured the binding
of 125I-labeled histone H4 to these cells. We found
that APP, either in the medium or on the cell-surface,
protected the cells against histone-induced toxicity.
Portions of this work were published in abstract form
 .  .in Neurobiol. Aging 15 Suppl. 1 , 1994 S85.
2. Materials and methods
2.1. Materials
Native histones were prepared from calf thymus
chromatin by the adsorption of DNA to hydroxy-
w xapatite 16 . The preparations contained nucleosomal
 .histones histones H2, H3, H4 , histone H1 and less
than 2% wrw DNA. SDS-polyacrylamide gel elec-
 .trophoresis PAGE and staining revealed no other
proteins in the preparation. Purified histone H4 and
 .the protease inhibitor cocktail tablets Completee
were obtained from Boehringer-Mannheim. RPMI
1640 medium, fetal bovine serum and penicillin-
streptomycin-amphotericin B were products of Gibco
 .BRL. Insulin-transferrin-selenium ITS was pur-
chased from Upstate Biotechnology. The U-937 cells
 w x.  .CRL 1593 17 and COS-7 cells CRL 1651 were
purchased from the American Type Culture Collec-
tion. These cell lines tested negative for mycoplasma
w3 x 125contamination. H Thymidine and Na I were ob-
tained from ICN Biomedicals. The indicator dye
alamarBlue was supplied by Alamar Biosciences
 .  .Sacramento, CA . Brefeldin A BFA and cy-
tochrome c were purchased from Sigma. The reagent
 .sulfosuccinimidyl 2 biotinamide ethyl 1,3-di-
thiopropionate was obtained from Pierce. APP-751
was synthesized in a baculovirus-expression system
w x12 and sAPP was purified as previously described
w x12 . The COS-7 cells were transfected using Lipo-
 .  .fectin BRL with the pMEP4 vector Invitrogen
alone or the vector containing a hammerhead ri-
bozyme directed toward the mRNA encoding bAPP
and were isolated and cloned using hygromycin as
w xdescribed previously by Denman et al. 18 .
2.2. Methods
3 5 Approximately 5P10 –1P10 cells adapted to a
serum-free or low-serum medium, with ITS as a
.serum substitute in 50–100 ml were placed in the
wells of a Falcon 96-well plate. The cells attached to
the wells during the overnight incubation at 378C in a
5% CO atmosphere. Medium was then removed and2
 .H4 or sterile water was added from a 10 mgrml
stock solution in water to achieve final concentrations
of 0 to 8.85 mM in 50–100 ml RPMI-ITS. Parallel
experiments were run with a similar range of concen-
trations of mixed, native histones as a control for
. activity or cytochrome c as a control molecule of
.about the same size and charge as H4 . The cells
were maintained in these media for periods up to 24
w3 xh. Cell viability was measured either by H thymi-
dine incorporation or alamarBlue fluorescence.
2.2.1. Thymidine incorporation
DNA synthesis was measured by the addition of
w3 x  .H thymidine-containing medium 1 mCirml to
each well for 2 h at 378C. The cells were washed
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with cold PBS and lysed with a buffer composed of
2% NP-40, 1% deoxycholate, 0.14 M sucrose, and
 .0.05 M Tris pH 7.5 . The lysate and a PBS wash of
each well were filtered over a Whatman glass mi-
crofiber filter. The filters were washed three times
with 0.1% SDS, solubilized in 0.1 M NaOH, neutral-
ized in 0.1 M HCl, and counted in Ecoscint A.
Background values were determined from wells that
lacked cells.
2.2.2. AlamarBlue assay
One-tenth volume alamarBlue dye was added to
the medium in each well of cells and to blank wells
containing medium but no cells. The plates were
incubated for 3 h at 378C. The reduction of the
alamarBlue indicator dye to a fluorescent form visi-
.ble as a shift from blue to pink color was measured
in an Hitachi fluorimeter or a Millipore Cytofluor
2300 fluorimeter 560 nm excitation filter, 590 nm
.emission filter .
2.2.3. Effects of sAPP
Effects of sAPP on cell viability in the presence
and absence of histone: Purified sAPP was reconsti-
tuted in medium. Histone alone, histone plus sAPP or
sAPP alone were added at various concentrations.
Cells without any added agent served as controls. The
 .cells were incubated for 3 h at 378C 5% CO and2
their viability was measured by the alamarBlue assay.
2.2.4. Measurements of APP
Measurements of APP in U-937 and COS-7 lines
were made by protein extraction, SDS-PAGE and
w xwestern blotting as previously described 10 . To aid
in APP detection in the U-937 cells, the cells were
 .exposed to Brefeldin A BFA, 10 mgrml for 2 h to
prevent secretion of APP before protein extraction.
After electrophoresis and transfer, blots were probed
with rabbit polyclonal antibody R57 directed against
w xthe C-terminus of APP 10 . APP was visualized with
goat anti-rabbit IgG coupled to alkaline phosphatase
followed by 5-bromo-4-chloro-indoyl phosphate and
nitro blue tetrazolium. The levels of APP in cell
extracts were quantified by the photometric scanning
of blots, with a Mirror Technologies flat-bed scanner
interfaced to a Macintosh Centris 650 computer and
Adobe Photoshop acquisition software. The images
were quantified with Signal Analytics gel analysis
software. To minimize possible nonlinearity, the sam-
ple loads were adjusted to yield similar staining
densities. The extent of the ribozyme-induced de-
crease in APP was calculated from the relative stain-
ing densities. The cellular APP level was determined
from the staining density of known amounts of APP-
w x751 12 .
2.2.5. Cellular binding of H4
w xHistone H4 was iodinated with chloramine T 19
 8 .specific activity 10 cpmrmg and was purified by
size exclusion chromatography. COS-7 cells, stably
transfected either with a vector encoding a ribozyme
directed toward APP mRNA or with the vector alone
w x18 and adapted to low serum medium, were grown
for 4 days to a density of 105 cellsrcm2 in 35 mm
diameter tissue culture dishes. The cells were incu-
bated at 228C with 125I-histone H4 in 1 ml RPMI
containing 25 mM Hepes and 1 mgrml BSA for 30
min. After the incubation, the cells were washed free
of unbound histone with PBS, lysed in 1% SDS and
briefly sonicated to shear DNA. An aliquot was
counted in a liquid scintillation counter, and another
aliquot was assayed for protein by the Pierce bicin-
 . w xchoninic acid BCA procedure 20 . To correct for
differences in cell number, the amounts of bound
radioactivity were normalized by the amount of cellu-
lar protein.
2.2.6. Quantification of cell-surface APP
COS-7 cells were plated on 35 mm dishes at a
density of 5P105 cellsrdish and cultured for 2 days
to a density of 106 cellsrdish. The monolayers were
washed with PBS and they were treated with the
impermeant reagent sulfosuccinimidyl 2 biotina-
.  .mide ethyl 1,3-dithiopropionate 0.5 mgrml in 1 ml
PBS, 1 mM CaCl at 188C for 30 min. The cells2
were washed and lysed with 1% Triton X-100 PBS
containing the protease inhibitor cocktail ‘Complete’.
The biotinylated proteins were adsorbed to strepta-
vidin-agarose. Cultures untreated with the biotinyla-
tion reagent served as controls.
The bound proteins were eluted with PAGE sam-
ple buffer and were subjected to PAGE. The relative
amounts of total APP and biotinylated APP were
determined by immunoblot analysis. The blots were
developed with antiserum R57 directed to the
COOH-terminus of bAPP and were quantified by
w xphotodensitometry 21 .
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3. Results
The effects of histone exposure on cell survival
and proliferation were initially assessed by morphol-
 .ogy. Serial dilutions of H4 from 8.85 mM were
added to U-937 cells adapted to a serum-free medium.
Within 5 min of the addition of the highest dose of
histone H4, the cells swelled to about 4= their
original volume. By 30 min all had ruptured. In
contrast, about half of the cells exposed to 4.43 mM
H4 were swollen at 5 min and all were dead by 1 h.
When exposed to 2.2 mM H4, some cells appeared
swollen at 5 min, but most appeared to survive, even
after 4 h exposure. Histone H4 levels below this
concentration did not affect the cells’ appearance.
To quantitate the effect of H4 upon U-937 cell
w3 xmetabolism, H thymidine incorporation was mea-
sured at two times: 30 min and 24 h. The results
illustrate that by 30 min the effects of H4 are virtu-
ally complete; most cells that are destined to die no
 .longer incorporate thymidine Fig. 1A . The IC for50
thymidine incorporation was calculated to be 1.5 mM
 .17 mgrml H4.
The H4 toxicity test was repeated using the ala-
marBlue assay. The results were essentially the same
w3 xas those obtained by measuring H thymidine incor-
 .poration compare Fig. 1B with Fig. 1A ; therefore,
this assay was adopted for further measurement of
histone toxicity. The addition of similar concentra-
tions of cytochrome c, of similar size and charge, had
 .no effect on cell viability Fig. 1B . Together these
data show that H4 at micromolar concentrations not
only inhibits DNA replication in U-937 cells, but also
inhibits their general metabolic activity.
Native calf thymus histones were used to test
whether the toxic effects of commercially purified
histone H4 might be due primarily to the presence of
denatured H4 in the preparation. Native calf thymus
w xhistones had been shown to be toxic as a group 15 .
When compared on a weight basis the native histone
preparation was nearly 2-fold more toxic than com-
 .mercial, purified histone H4 Fig. 1B ; therefore, we
concluded that if there is any denatured H4 in the
commercial, purified preparations, it is relatively less
toxic than native histones, including native H4.
The mechanism by which histones kill cells is
w xunknown. Since histones bind APP 13 , we enter-
tained the alternative hypotheses that APP either
Fig. 1. Histone H4 toxicity tests on U-937 cells. A. U-937 cells
were incubated in the presence of varying concentrations of
 .  .histone H4 for 30 minutes open square or 24 h filled square .
w3 xH thymidine was added and the incubation continued for 2 h.
Resulting incorporation of label was calculated as per cent of
untreated control incorporation. Data points represent the mean
derived from several experiments carried out with each sample
done in triplicate. Error bars represent"one sample standard
deviation from the mean B. U-937 cells were incubated in the
presence of increasing concentrations of histone H4 filled
.  .square , mixed native histones open squares , or cytochrome c
 .open circles for 4 h. AlamarBlue was added and the cells
incubated 3 more hours total of 7 h in the presence of agent
.added . The resulting fluorescence was measured and the data
represented as percent of control fluorescence.
mediated histone toxicity or protected cells from this
toxin. To test the hypothesis that APP prevents his-
tone toxicity we added exogenous APP in the pres-
ence and absence of histone.
When cells were exposed to H4 at 1, 2 and 4
.mM , equimolar amounts of sAPP protected the cells
 .from the toxic effects of the histone Fig. 2A . sAPP
( )J.R. Currie et al.rBiochimica et Biophysica Acta 1355 1997 248–258252
Fig. 2. sAPP protection against histone H4 toxic effects on U-937
cells. A. Each well of a 96 well plate contained 5P103 cells in a
 .total volume of 50 ml. sAPP 1, 2 or 4 mM was added to one set
of wells, while the other set received the vehicle alone. Immedi-
ately after the addition of sAPP, matching concentrations 1, 2 or
.4 mM of H4 were added to both sets of wells. After the plates
were incubated for 3 h at 378C, the alamarBlue cell viability
 .assay was performed. H4 alone black columns ; H4 plus sAPP
 .grey columns . B. Increasing concentrations of histone H4 alone
or sAPP alone or an equimolar mixture of H4 and sAPP were
 .added to U937 cells. H4 alone, black columns , H4 plus equimo-
 .  .lar sAPP grey columns , sAPP alone white columns . The
incubations and assays were performed as described in panel A.
also promoted cell aggregation and general cell
 .metabolism as measured by dye conversion . These
effects were dose-dependent; the higher sAPP con-
centrations increased the rate of aggregation to the
greatest extent. 1 mmol sAPP was sufficient to pro-
tect the cells from H4 at 1, 2 and 4 mM concentra-
 .tions Fig. 2B . Thus sAPP was able to protect the
cells even at a four-fold lower molar concentration.
Since even 1 mM sAPP could protect the cells from
histone toxicity, we determined the relative amount
of sAPP at which the protective effect disappeared.
Serial dilutions of sAPP from 1 mM were added to
cells exposed to 2 mM H4, a concentration of H4
which normally kills approx. 80% of the cells. sAPP
at concentrations of 0.5 mM and above completely
protected the cells from H4 toxicity a molar ratio of
.  .histone to APP of 4:1 Fig. 3A . Below this concen-
tration, cell survival decreased. At 0.015 mM and
below, sAPP provided no protection from the toxic
effects of 2 mM H4. Similar results were obtained
when sAPP was added to native, mixed histones Fig.
.3B .
Fig. 3. Protection of U-937 cells from histones by increasing
concentrations of sAPP. Increasing concentrations of sAPP were
added to U-937 cells and the cells were then exposed to A: 2 mM
 .histone H4 23 mgrml or B: 20 mgrml mixed, native histones.
Incubations and assays were performed as described in Fig. 2.
The fluorescence yields were normalized by the fluorescence
yield of U-937 cells to which no H4 or sAPP had been added.
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Fig. 4. Levels of APP expression in U-937 and COS-7 cell lines. APP was extracted from U-937 cells, COS-7 cells and COS-7 cells
transfected with an APP mRNA-directed ribozyme DNA-containing vector or the vector alone. Gels were stained with Coomassie Blue
 .  .B and D or blotted and subsequently immunostained with an APP C-terminus antibody, R57 A and C . Brackets on left denote the
 .bands of APP isoforms. Relative molecular mass markers kDa are to the left. One sample of U-937 cells was exposed to BFA for 2 h to
 . trap the APP in the cell and aid in its detection. With a protein load of 10 mgrlane B , APP is barely detectable in U-937 cells A, first
.  .lane unless the APP is retained in the cell by the presence of BFA A, second lane . When all 4 cell types are run at a protein load of 5
 .  .mgrlane D , APP is not visible on the immunoblot in U-937 cells C . The presence of the ribozyme decreases APP expression by 80%
 .compared to the normal cell line or the cells transfected with the vector alone C .
U-937 cells synthesize so little APP compared to
 .COS-7 cells Fig. 4C and D , that its presence cannot
be demonstrated on Western blots under conditions in
which APP is easily detected in COS-7 cells. How-
ever, the exposure of U-937 cells to Brefeldin A
 .BFA for 2 h traps APP in the cells and facilitates its
 .detection Fig. 4A and B . COS-7 cells express much
 .higher levels of APP Fig. 4C . From the densito-
metric analysis of immunoblots of COS-7 extracts,
we calculated that COS-7 cells contained 7 ng
APPrmg total cell protein, whereas U-937 cells con-
tained 5% of this amount. COS-7 cells stably trans-
fected with an APP-specific ribozyme contained 20%
of the amount of APP in untransfected COS-7 cells
 . w xFig. 4C and D as we had previously reported 18 .
When COS-7 cells adapted to low-serum medium
were exposed to H4, they were much more resistant
 .to its toxic effects than U-937 cells Fig. 5 . COS-7
cell metabolism was unaffected by H4 concentrations
below 2 mM. While 7 mM H4 killed all the U-937
cells, about 35% of the COS-7 cells survived this
dose. The LD for the COS-7 cells was 5.4 mM H450
as compared to that for the U-937 cells of 1.5 mM
H4.
To test whether the differential survival of COS-7
and U-937 cells was related to differences in APP
levels, the survival of COS-7 cells was compared to
that of two transfected COS-7 cell lines: one express-
ing an APP mRNA-directed ribozyme and the other
carrying the expression vector alone as a control. The
steady-state APP level in the ribozyme-expressing
Fig. 5. Histone H4 toxicity assay of different COS-7 cell types in
the presence of histone H4 compared to U-937 cells. COS-7
cells, COS-7 cells transfected with the APP-ribozyme and COS-7
cells transfected with vector alone were incubated in the presence
of varying concentrations of histone H4 for 4 h. Cell viability
 .was measured after 3 h 7 h total in the presence of H4 as
described in the text. The data are presented as per cent of control
fluorescence. The corresponding data from the U-937 cells are
 .presented for comparison. U937 filled square COS-7 ribozyme
 .  .open triangles , COS-7 cells vector alone open circles COS-7
 .cells open squares .
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cells was reduced by approximately 80% compared
to the level in untransfected COS-7 cells or COS-7
cells transfected with the vector alone Fig. 4C and
.D . However, these levels were still more than four
times greater than those in the U-937 cells Fig. 4A
.and C . When COS-7 cells were exposed to different
concentrations of H4, the ribozyme-expressing cells
were more sensitive to the toxic effects of histone
 .LD s3.2 mM than the cells carrying the vector50
alone or the original untransfected COS-7 cell line
 .Fig. 5 .
A biotinylation experiment demonstrated that APP
does reside on the surface of COS-7 cells. In 3
experiments we found that 7"0.5% of mature APP
was biotinylated and specifically adsorbed to strepta-
vidin-agarose. This is a lower limit because we did
not have controls for partial biotinylation and partial
recovery of biotinylated APP. APP has also been
shown to be located on the plasma membranes of
w xMadin-Darby canine kidney cells 22,23 and human
w xumbilical vein endothelial cells 24 .
To confirm that cell-surface APP could bind his-
tones, we studied the interaction of labeled histone
H4 with COS-7 cells. The binding of histone H4 to
cell-surface APP was demonstrated by comparing the
affinity of 125I-labeled histone H4 for COS-7 cells to
that for APP-depleted COS-7 cells. We found that, at
concentrations below 1 nM, the binding of 125I-labeled
histone H4 to ribozyme-containing cells was reduced
 .by two-thirds Fig. 6A . Because the ribozyme-con-
taining cells still expressed APP at a level about 20%
of that of cells transfected with vector alone, we
concluded that, in this concentration range, about
80% of the binding of 125I-labeled histone H4 to
COS-7 cells occurs through cell-surface APP.
The binding of 125I-labeled H4 to COS-7 cells
increased with H4 concentation; however, the binding
to cell-associated APP appeared to saturate at about
 .100 nM H4 Fig. 6B . Histone H4 binding exhibited
positive cooperativity, with a Hill coefficient of 1.6
 .Fig. 6C . This result may reflect the interaction of
histone H4 with 2 APP molecules to form a dimer
possessing greater affinity for another H4 molecule.
On the other hand, it may result from preferential
binding of H4 dimers, which would form at higher
H4 concentrations. The H4 concentration at half-
saturation was about 40 nM, which is similar to the
 .value of the dissociation constant 27 nM previously
Fig. 6. 125 I-labeled histone H4 binding to COS-7 cells. The
binding of 125I-labeled histone H4 to COS-7 cells transfected
 .with the APP-mRNA-directed ribozyme triangles and those
 .transfected with the vector alone circles was measured as
described in the text. The cells were incubated with 125I-labeled
 6histone H4 at either high specific activity 10 cpmrpmol, panel
.  4 .A or low specific activity 3P10 cpmrpmol, panel B . The
 .APP-associated binding open triangles was calculated as the
difference between the binding to control cells and to the ri-
bozyme-containing cells. The APP-associated binding was ex-
 .pressed as a Hill plot panel C , where y is the fraction of
saturation. The extent of binding at saturation was calculated
from a double-reciprocal plot of the APP-specific binding data in
 .panel B result not shown . In the experiment reported in panel
A, the APP level in the ribozyme-containing cells was reduced by
80%. In the experiment recorded in panel B, the APP level was
reduced by 60%. The latter experiment was conducted 3 times
with similar results. These results were not averaged because of
differences in the APP levels in the ribozyme-containing cells.
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calculated for the binding of soluble APP to
w xSepharose-bound H4 13 .
4. Discussion
Concentrations of histone H4 greater than 1 mM
rapidly kill monocytic U-937 cells with an LD of50
1.5 mM. Another protein of similar size and charge,
cytochrome c, has no effect on cell viability, suggest-
ing that the toxic effects of H4 are specific to the
presence of that protein. Whereas sAPP in the micro-
molar range has no effect on the proliferation of
U-937 cells, sAPP protects U-937 cells from H4
toxicity. We previously demonstrated that sAPP binds
H4 with a dissociation constant in the 10 mM range
w x13 . In contrast, COS-7 cells, fibroblastic cells which
synthesize and secrete a larger amount of APP, were
less sensitive to the toxic effects of H4. Since replac-
ing the medium when the histone is added removes
all secreted APP and since the histone effects are so
rapid, the protection by APP that is observed is likely
due to the greater number of APP molecules on the
COS-7 cell surface rather than an increased amount
of sAPP in the medium.
COS-7 cells, in which the level of APP had been
reduced by 80% by the expression of an APP-
mRNA-directed ribozyme, were more sensitive to H4
than cells that expressed the vector alone, but were
still more resistant than the U-937 cells. Thus their
resistance to histones increased with their relative
steady-state APP levels. The 125I-labeled H4 binding
studies indicate that H4 binds to the surface of COS-7
cells. The cells that express the APP-directed ri-
bozyme, and therefore synthesize less APP, bound
less H4 than those expressing the vector alone. At
nanomolar H4 concentrations the primary receptor
for H4 appears to be APP, because about two-thirds
of the binding of H4 was eliminated when the cellu-
lar APP content was reduced by 80%. The residual
H4-binding may also represent association to APP
w xand APP-like proteins 25,26 . The latter proteins are
not affected by the ribozyme; however, they may
bind H4.
APP processing proceeds along complex pathways
that involve its transport to most of the major or-
w xganelles, except mitochondria 11 . A large fraction
undergoes transport along the constitutive secretory
pathway, where it is cleaved in the late Golgi or on
w xthe plasma membrane and exits the cell 27–29 .
Another fraction exists for a time on the plasma
membrane, from which it is reinternalized and trans-
w xported either to the endosomal-lysosomal system 30
or back to the Golgi. Still another fraction enters
w xnuclear membranes 11 . We presume that the cell-
surface APP binds H4 and later transports it to
lysosomes, where it is degraded.
The cytotoxicity of histones and histone fragments
has been widely reported. Arginine-rich histones such
as H4 manifest bacteriocidal activity toward E. coli
 .and other species LD s0.3 mgrml by binding to50
the bacterial cell surface, causing damage to the
w xosmotic barrier and cell respiration 14 . Storage
granules in activated macrophages contain antimicro-
bial proteins that are similar or identical to some
w xhistones 31 . These granules not only fuse with
phagolysosomes, but may also release these histone-
like proteins to the cell surface. In one of the earliest
accounts of the effects of total thymic histones on
w xcells, Becker and Green 15 reported that histones
enter mouse ascites tumor cells rapidly and affect
their viability. The changes in morphology which we
observed for the histone-treated U-937 cells and
COS-7 cells were similar to those reported by Becker.
The cells first showed severe cytoplasmic swelling,
while the nucleus became more discrete; then the
cells rapidly ruptured. The effects were seen within
five minutes at high histone concentrations. Others
have reported that histones can reduce DNA and
w xRNA synthesis, cause a loss in viability 32 , change
w xcellular morphology and confluent density 33 , cause
w xcytolysis 34 , and decrease both aerobic and anaero-
w xbic metabolism 35 . The binding of basic fibroblast
growth factor to the fibroblast cell surface can also be
w x w xblocked by histones 36 . Ginsberg 37 reported that
polylysine and polyarginine were quite toxic for lym-
phocytes at a concentration of 0.5 mM. Histones and
other polycations are also potent activators of
w xmacrophages and neutrophils 38,39 . Histones and
other native cationic proteins might regulate several
leucocyte functions and affect the progress and out-
w xcome of inflammatory events 38 . Specific cell sur-
face receptors on macrophages may mediate the se-
lective uptake of positively charged proteins, includ-
ing some autoantigens; basicity may be a common
element of many protein and peptide ligands, possi-
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bly facilitating interaction with negatively charged
cell surface structures such as phospholipids, proteo-
w xglycans and receptors 39 .
The toxic effects of H4 are not mediated by cell
surface APP, because APP becomes saturated below
 .100 nM H4 Fig. 6 ; whereas, H4 exerts its cytolytic
 .effect at concentrations above 1 mM Fig. 1 . At
0.1–1 mM concentrations H4 binds to other cell
surface components, which must mediate the cy-
tolytic effect. By preferentially binding H4, cell-
surface APP would protect cells from H4’s toxicity.
Qualitatively, this effect was observed in the en-
hanced susceptibilities of COS-7 and U-937 cells
with lowered APP levels. Absolute protection is diffi-
cult to demonstrate in a conventional cell culture
system, because of the large ratio of medium volume
to cell volume. The amount of H4 needed to attain
cytoxic concentrations to sufficiently populate the
.toxic binding sites overwhelms the limited amount
of cell-associated APP. Nevertheless, one would pre-
dict that in living tissues, which possess low ratios of
extracellular volume to cell surface, both sAPP and
cell-associated APP would effectively sequester ex-
tracellular histones.
Soluble APP protects cells against 4 molar equiva-
lents of H4 or 2 molar equivalents of mixed histones
 .Fig. 5 . APP may possess 4 separate H4-binding
sites; however, since histones readily form dimers,
tetramers and octamers, the multimers may be the
predominant species in our assay conditions. In addi-
tion, sAPP may tightly bind the dimer or tetramer and
drive the equilibrium to this species. The results of
the 125I-labeled H4 binding study at 10- to 100-fold
lower H4 concentrations suggest that a multimeric
form, possibly a dimer, bound to cell-associated APP.
Histone proteins are characteristically thought to
be confined to the nucleus where they are linked to
DNA replication and transcription regulation and are
w xusually localized to chromatin 40,41 . They bind to
each other, to DNA, to receptors and to other factors
which regulate gene transcription. But histones ap-
pear to have other, non-chromatin-related functions
as well. Soluble histones are found in bovine milk
and serum at concentrations up to 0.003% of total
w xprotein 42 . Histones are also transported through the
w x w xblood-brain-barrier 43 . Ryser and Hancock 44 re-
ported that histone, in a concentration less than 100
mgrml, was taken up by cells at rates up to 3000
times greater than that of serum albumin. Arginine-
rich histones such as H4 were taken up more readily
than the lysine-rich histones. Histones H2A, H2B, H3
and H4 have been found in the T cell plasma mem-
w xbrane fraction 45 and on the surfaces of human
w x w x w xmonocytes 46 , B cells 47 , cytotoxic T cells 48 ,
w xendothelial cells 49 , the Raji lymphoblastoid cell
w x w xline 50 and sperm 51 . Histone H4 has been found
on the surface of peripheral blood monocytes
w x w x49,52,53 . Jacob et al. 54 reported that a mono-
clonal anti-DNA autoantibody when complexed with
histone binds to a 94 kDa cell surface protein on
various cell types which colocalizes with clathrin.
Finally, Emlen reported that receptors for chromatin
were induced when monocytes were activated. He
proposed that monocytes may provide an important
mechanism for the removal of the extracellular nu-
clear material at the site of inflammation or cell death
w x46 . When cells are damaged or die, histones or
histone fragments would be expected to be released
into the local intercellular media. Under these condi-
tions, histones or histone fragments, at low concentra-
tions, could stimulate glucose uptake, amino acid
uptake and growth in nearby cells to compensate for
the injury and, at higher concentrations, cause further
cell death. Our studies suggest that cell surface and
secreted APP may bind histones in serum and in
tissues in order to remove cellular debris from injured
tissue or tissue undergoing programmed cell death,
from nuclear elimination during erythrocyte matura-
tion or to prevent the generation of pathogenic antin-
uclear antibodies.
Further research is required to determine the sig-
nificance of the toxic effect of histone as well as to
identify the mechanism by which histones exert this
effect when they bind to the cell surface. Our find-
ings indicate that APP can protect cells from
histone-mediated toxicity, and this system could prove
useful in deducing the diverse functions of APP. The
practical consequence of APP’s capacity to bind his-
tones is that these toxic substances would be taken
into the endosomal-lysosomal system and degraded.
APP binds other substances such as proteoglycans
w xand proteases 5,8 , which would also be cleared from
the extracellular milieu by this process. Our studies
raise the possibility that the clearance of extracellular
substances may be an important role of both cellular
and secreted APP.
( )J.R. Currie et al.rBiochimica et Biophysica Acta 1355 1997 248–258 257
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